US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion. The American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback